News & Events - Memic - Robotics Surgery Made Natural Hominis™

News & Eventsmonimono2021-03-01T20:57:03+00:00

News: Memic Receives FDA De Novo Marketing Authorization for First-Ever Surgical Robotic System with Humanoid-shaped Robotic Arms

Hominis^® robot-assisted surgical platform now available for use in transvaginal gynecologic procedures including benign hysterectomy

News: Clinical experience with a robotic assisted system for transvaginal gynecologic surgery

Presentation given at the American Urogynecologic Society Meeting

News: Memic Performs First Israel Case in Transvaginal Hysterectomy Study

The procedure was performed by Prof. Lior Lowenstein of Haifa’s Rambam Healthcare Campus

News: Hominis Used in First Transvaginal Robotic Hysterectomy in Belgium

In a first-of-its-kind procedure in Belgium, Dr. Jan Baekelandt of Bonheiden’s Imelda Hospital has performed a transvaginal robotic-assisted hysterectomy using Memic’s technology

News: Memic Initiates Clinical Trial of Innovative Transvaginal Robotic Hysterectomy

a two-center clinical trial to investigate the use of the company’s cutting-edge Hominis robotic platform in the performance of transvaginal hysterectomy

News: Memic Appoints Dr. Maurice Ferré Chairman of BOD Following $10M Financing Round

Signing on as a private investor, Mr. Ferré has over 20 years of experience in the medical device industry

News: Memic’s Hominis® robotic-assisted surgical platform granted patent for both method and device for hysterectomy

In a major leap for the company’s intellectual property, Memic has been granted a US patent for its Hominis® robotic-assisted surgical platform, securing both the device itself and its unique method for transvaginal hysterectomy

Indications for use: The Hominis® Surgical System is an endoscopic instrument control system that is intended to assist in the accurate control of the Hominis Arms® during single site, natural orifice laparoscopic-assisted transvaginal benign surgical procedures listed below. The Hominis® Surgical System is indicated for use in adult patients. It is intended to be used by trained physicians in an operating room environment. The representative uses of the Hominis® Surgical System are indicated for the following benign procedures: Total Benign Hysterectomy with Salpingo-Oophorectomy • Total Benign Hysterectomy with Salpingectomy • Total Benign Hysterectomy • Salpingectomy • Oophorectomy • Adnexectomy • Ovarian cyst removal. Caution: The safety and effectiveness of the Hominis® Surgical System was established only for the representative uses mentioned in the Indications for Use. The demonstration of safety and effectiveness for the representative specific procedures did not include evaluation of outcomes related to the treatment of cancer (overall survival, disease-free survival, local recurrence) or treatment of the patient’s underlying is ease/condition. Device usage in all surgical procedures should be guided by the clinical judgment of an adequately trained surgeon. The prescription-use symbol or “Caution: Federal law restricts this device to sale by or on the order of a physician.” For safety information, including risks, indications, and specific warnings and cautions related to the Hominis System please refer to the Hominis Surgical System Instructions for Use provided with your Hominis Surgical System.